US Patent Issued to CEVA SANTE ANIMALE on Sept. 8 for "Controlled-release progesterone compositions and uses thereof" (French Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,133, issued on Sept. 8, was assigned to CEVA SANTE ANIMALE (Libourne, France).

"Controlled-release progesterone compositions and uses thereof" was invented by Florence Guimberteau (Libourne, France) and Sandrine Lacoste (Libourne, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition comprising between 35 and 55% by weight of a polymer matrix comprising a thermoplastic polymer having a Shore A hardness of between 20 and 100 as measured by a Type A durometer according to the ASTM D2240 standard and a melting point of between 40 and 200deg C.; and between 30 and 55% by weight of progesterone relative to t...